Genetic susceptibility to nicotine addiction: Advances and shortcomings in our understanding of the CHRNA5/A3/B4 gene cluster contribution.

Icick R, Forget B, Cloëz-Tayarani I, Pons S, Maskos U, Besson M

Open source

DOI
10.1016/j.neuropharm.2020.108234
Published
2020 Oct 15
Container
Neuropharmacology
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.neuropharm.2020.108234,
  title = {Genetic susceptibility to nicotine addiction: Advances and shortcomings in our understanding of the CHRNA5/A3/B4 gene cluster contribution.},
  author = {Icick R and Forget B and Cloëz-Tayarani I and Pons S and Maskos U and Besson M},
  year = {2020},
  journal = {Neuropharmacology},
  doi = {10.1016/j.neuropharm.2020.108234},
  url = {https://doi.org/10.1016/j.neuropharm.2020.108234}
}

RIS

TY  - JOUR
TI  - Genetic susceptibility to nicotine addiction: Advances and shortcomings in our understanding of the CHRNA5/A3/B4 gene cluster contribution.
AU  - Icick R
AU  - Forget B
AU  - Cloëz-Tayarani I
AU  - Pons S
AU  - Maskos U
AU  - Besson M
PY  - 2020
JO  - Neuropharmacology
DO  - 10.1016/j.neuropharm.2020.108234
UR  - https://doi.org/10.1016/j.neuropharm.2020.108234
ER  - 

APA

R, I., B, F., I, C., S, P., U, M., & M, B. (2020). Genetic susceptibility to nicotine addiction: Advances and shortcomings in our understanding of the CHRNA5/A3/B4 gene cluster contribution.. Neuropharmacology. https://doi.org/10.1016/j.neuropharm.2020.108234

Source records